Vital Signs

Showing 21-30 of 307

02 Oct 2006  |  North America

Vital Signs - Genetic Screening: Saving Time and Money

 

This issue of Vital Signs, released on October 2, 2006, provides a strategic overview and discussion of the potential impact of genetic screening in Alzheimer's therapy. Additionally, an emerging company profile is provided for The Medicines Company, a company that specializes in providing and developing pharmacutical products for the acute care ho...

USD 1,500.00

This issue of Vital Signs, released on October 9, 2006, provides a strategic overview and discussion of the use of biomarkers in clinical trials. Additionally, an emerging company profile is provided for Dendritic Nanotechnologies Inc., a company that specializes in the development and commercialization of dendrimers and dendritic polymers. Reimbur...

USD 1,500.00

This issue of Vital Signs, released on October 16, 2006, provides a strategic overview and discussion of the potential impact on home telehealth by the Continua Health Alliance. Additionally, an emerging company profile is provided for Computerized Screening, Inc., a leader the area of patient oriented monitoring devices. Reimbursement and regulato...

USD 1,500.00

This issue of Vital Signs, released on October 23, 2006, provides a strategic overview and discussion of the potential impact of drug and gene therapy on the amount of angioplasty procedures in clinical practice. Additionally, an emerging company profile is provided for Foxhollow Technologies Inc., a leader in the development and manufacturing of p...

USD 1,500.00

This issue of Vital Signs, released on October 30, 2006, provides a strategic overview of the application of radio frequency identification (RFID) in pharmaceutical supply chain management. Additionally, an emerging company profile is provided for Surface Logix, Inc., a drug development company that utilizes proprietary biophysical chemistry for th...

USD 1,500.00

This issue of Vital Signs, released on November 6, 2006, provides a strategic overview of personalized medicine and pharmacogenomics. Additionally, an emerging company profile is provided for Microchip Biotechnologies, a leading provider of microchip based biosample preparation systems for the biodefense and genomics industries. Reimbursement and r...

USD 1,500.00

This issue of Vital Signs, released on November 13, 2006, provides a strategic overview of the prospects of PACS for providing the imaging component of a US-wide, image-enabled EMR. Additionally, an emerging company profile is provided for Commissure Inc., a medical imaging company dedicated to the creation of convergence technologies that assure m...

USD 1,500.00

This issue of Vital Signs, released on November 20, 2006, provides a strategic overview of the impact of rules-based information systems. Additionally, an emerging company profile is provided for Click4care, Inc., an innovator in providing software solutions for healthcare supply chains. Reimbursement and regulatory news from the FDA and CMS is als...

USD 1,500.00
27 Nov 2006  |  North America

Vital Signs - Stay Connected

 

This issue of Vital Signs, released on November 27, 2006, provides a Q&A session with Gerry Purdy, VP and Chief Analyst, Information and Communication Technologies, on the use of wireless communications in the pharmaceutical sector. Additionally, an emerging company profile is provided for MannKind Corporation, a leader in pulmonary insulin product...

USD 1,500.00

This issue of Vital Signs, released on December 4, 2006, provides a strategic overview of the market for urinary catheters. Additionally, an emerging company profile is provided for Opticon Medical, a leader in the development of innovative products for urinary management. Reimbursement and regulatory news from the FDA and CMS is also provided for ...

USD 1,500.00

Showing 21-30 of 307